Close
Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
Show source BACK TO LIST

Laboratory Report

Patient
Name: Toscano, Abbondanzio
DOB: 04-JUL-1979 (Age: 46)
Gender: male
Address:
Via del Viminale 11
09033 Decimomannu (Italy)
ID: 2005-291300-9
Report
Date: 11-MAR-2025
Laboratory
Requested by
Poliambulatorio ASL
(Italy)
Specimen
Collected: 10-MAR-2025

Chemistry

Test 10 Mar 2025 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.1 H 4.3 - 6 %
Glucose [Mass/volume] in Blood 86.4 70 - 110 mg/dL
Urea nitrogen [Mass/volume] in Blood 15.9 7 - 45 mg/dL
Creatinine [Mass/volume] in Blood 1.4 H 0.9 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 10.0 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 143.4 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 5.0 3.5 - 5.3 mmol/L
Chloride [Moles/volume] in Blood 106.6 98 - 114 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 23.0 22 - 29 mmol/L

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows persistently elevated HbA1c, indicating suboptimal long-term glycemic control and possible prediabetes or early diabetes. Creatinine is slightly above normal, suggesting mild renal impairment. Other parameters, including electrolytes and glucose, are within normal limits. Recommend clinical follow-up for glycemic management and renal function monitoring.